These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15559030)

  • 1. Hypertriglyceridemia and low HDL: therapeutic considerations.
    Larsen ML
    Curr Opin Lipidol; 1994 Feb; 5(1):42-7. PubMed ID: 15559030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triglyceride as a risk factor for coronary artery disease.
    Gotto AM
    Am J Cardiol; 1998 Nov; 82(9A):22Q-25Q. PubMed ID: 9819100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertriglyceridemia: risks and perspectives.
    Gotto AM
    Am J Cardiol; 1992 Dec; 70(19):19H-25H. PubMed ID: 1466313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity.
    Rashid S; Watanabe T; Sakaue T; Lewis GF
    Clin Biochem; 2003 Sep; 36(6):421-9. PubMed ID: 12951168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL and triglyceride as therapeutic targets.
    Fruchart JC; Duriez P
    Curr Opin Lipidol; 2002 Dec; 13(6):605-16. PubMed ID: 12441884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):18B-25B. PubMed ID: 9526809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-density lipoprotein cholesterol, plasma triglyceride, and coronary heart disease: pathophysiology and management.
    Patsch W; Gotto AM
    Adv Pharmacol; 1995; 32():375-426. PubMed ID: 7748800
    [No Abstract]   [Full Text] [Related]  

  • 9. Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):1B-6B. PubMed ID: 9526806
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
    Breuer HW
    Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride, high density lipoprotein, and coronary heart disease.
    Consens Statement; 1992 Feb 26-28; 10(2):1-28. PubMed ID: 1286136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of fibrates in the regulation of triglyceride and HDL-cholesterol metabolism.
    Fruchart JC; Duriez P
    Drugs Today (Barc); 2006 Jan; 42(1):39-64. PubMed ID: 16511610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertriglyceridemia as a possible independent risk factor for stroke.
    Lisak M; Demarin V; Trkanjec Z; Basić-Kes V
    Acta Clin Croat; 2013 Dec; 52(4):458-63. PubMed ID: 24696996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Statin therapy for atherogenic hypertriglyceridemia].
    Koba S
    Nihon Rinsho; 2013 Sep; 71(9):1655-60. PubMed ID: 24205730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease.
    Sprecher DL; Watkins TR; Behar S; Brown WV; Rubins HB; Schaefer EJ
    Am J Cardiol; 2003 Mar; 91(5):575-80. PubMed ID: 12615263
    [No Abstract]   [Full Text] [Related]  

  • 16. [Increased triglycerides and/or low HDL cholesterol. A risk factor needing treatment?].
    Steinmetz A
    MMW Fortschr Med; 2002 Aug; 144(31-32):20-3. PubMed ID: 12422724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual dyslipidemia among United States adults treated with lipid modifying therapy (data from National Health and Nutrition Examination Survey 2009-2010).
    Wong ND; Chuang J; Wong K; Pham A; Neff D; Marrett E
    Am J Cardiol; 2013 Aug; 112(3):373-9. PubMed ID: 23642513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemfibrozil treatment of the high triglyceride-low high-density lipoprotein cholesterol trait in men with established atherosclerosis.
    Knipscheer HC; Nurmohamed MT; Van den Ende A; Plaat B; Pruijs HJ; Mulder WJ; Kastelein JJ
    J Intern Med; 1994 Oct; 236(4):377-84. PubMed ID: 7931040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparate effects of a triglyceride lowering diet and of bezafibrate on the HDL system: a study in patients with hypertriglyceridaemia and low HDL-cholesterol levels.
    Arnon R; Sehayek E; Eisenberg S
    Eur J Clin Invest; 1993 Aug; 23(8):492-8. PubMed ID: 8405002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gemfibrozil on the concentration and composition of serum lipoproteins. A controlled study with special reference to initial triglyceride levels.
    Mänttäri M; Koskinen P; Manninen V; Huttunen JK; Frick MH; Nikkilä EA
    Atherosclerosis; 1990 Feb; 81(1):11-7. PubMed ID: 2407250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.